Hambleton Julie - Insider Non-Derivative Transactions at SpringWorks Therapeutics, Inc. (SWTX) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Jul 1, 2025, Hambleton Julie's relationship to SpringWorks Therapeutics, Inc. (SWTX) is Director, and currently has 0 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other SWTX insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Hambleton Julie - Insider Non-Derivative Transactions of SWTX Common Stock

Hambleton Julie - Insider Non-Derivative Transactions at SWTX

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Jul 2, 2025	Disposition -- (Common Stock)	14155	0	0
May 15, 2025	Acquisition -- (Common Stock)	10060	0	14155
Feb 11, 2025	Sell -- (Common Stock)	13774	53.01	4095
Feb 11, 2025	M -- (Common Stock)	13774	32.27	17869
Jun 4, 2024	Sell -- (Common Stock)	20	42.09	4095
Jun 4, 2024	Sell -- (Common Stock)	931	41.49	4115
Jun 4, 2024	Sell -- (Common Stock)	751	40.57	5046
Jun 4, 2024	Sell -- (Common Stock)	2946	39.41	5797
May 17, 2024	Acquisition -- (Common Stock)	4095	0	8743
Jul 20, 2023	Sell -- (Common Stock)	2418	29.31	4648
Jun 21, 2023	Sell -- (Common Stock)	2400	26.92	7066
May 25, 2023	Acquisition -- (Common Stock)	4648	0	9466
Mar 16, 2023	Sell -- (Common Stock)	1106	31.5	4818